Latest news with #Frédéric
Yahoo
4 days ago
- Business
- Yahoo
Frédéric Robert appointed EUROAPI's Chief Commercial Officer overseeing API Solutions and CDMO activities
Press Release Paris – June 4, 2025 – EUROAPI, a European leader in the production of active pharmaceutical ingredients (API) and contract development and manufacturing organization (CDMO), is pleased to announce the appointment of Frédéric Robert to the newly created position of Chief Commercial Officer overseeing API Solutions and CDMO activities. He will join the company's Executive Committee. This appointment is part of EUROAPI's ongoing FOCUS-27 transformation plan and reinforces its position as a European leader in the API and CDMO sectors. In his new role, Frédéric Robert will be responsible for creating commercial and organizational synergies between the API Solutions and CDMO operations, delivering our FOCUS-27 sales plan and redefining a global sales strategy for the company. He will also be responsible for expanding the group's presence in its strategic markets and with its strategic clients, and optimizing its customer approach with integrated, high-value-added solutions. 'We are delighted to welcome Frédéric Robert to our team,' said David Seignolle, EUROAPI Chief Executive Officer. 'His extensive expertise in the pharmaceutical industry and CDMO space and his strategic vision for international markets will be invaluable assets to accelerate our growth. This appointment reflects our commitment to enhancing the convergence between our API and CDMO activities to deliver even more integrated and effective solutions for our clients.' Frédéric Robert brings a wealth of experience in the pharmaceutical industry, having held senior leadership roles at NAOS Bioderma, Fareva, and more recently at Aptar, where he served as Vice President of EMEA Sales & Customs Development. He has led several operations across Europe and North America, giving him a comprehensive understanding of the entire value chain, from API production to CDMO and CMO services. Frédéric Robert, Chief Commercial OfficerFrédéric Robert, a French national, joins EUROAPI after more than 25 years of experience in the development and commercialization of pharmaceutical products within international organizations. He previously held the position of Vice President of Sales & Customs Development EMEA at Aptar, overseeing nine commercial regions. Prior to this, Frédéric spent over a decade at Fareva as Senior Vice President of Global Sales & Marketing, where he led global commercial operations and served on the group's Executive Committee. Frédéric has also held several senior roles at Institut Esthederm and NAOS Bioderma, overseeing various subsidiaries across Central Europe and North America. There, he was responsible for business development, subsidiary management, and international expansion. He holds a Master's degree in International Marketing from the Dublin City University and a Master's degree in Business Administration (AES) from the University Jean Moulin Lyon 3. About EUROAPIEUROAPI is focused on reinventing active ingredient solutions to sustainably meet customers' and patients' needs around the world. We are a leading player in active pharmaceutical ingredients with approximately 200 products in our portfolio, offering a large span of technologies while developing innovative molecules through our Contract Development and Manufacturing Organization (CDMO) activities. Taking action for health by enabling access to essential therapies inspires our 3,430 people every day. With strong research and development capabilities and six manufacturing sites, all located in Europe, EUROAPI ensures API manufacturing of the highest quality to supply customers in more than 80 countries. EUROAPI is listed on Euronext Paris; ISIN: FR0014008VX5; ticker: EAPI). Find out more at and follow us on LinkedIn. Media Relations contact:Laurence BollackTel.: +33 (0)6 81 86 80 19mr@ Investor Relations contact:Sophie Palliez-CapianTel.: +33 (0)6 87 89 33 Certain information contained in this press release is forward looking and not historical data. These forward-looking statements are based on opinions, projections and current assumptions including, but not limited to, assumptions concerning the Group's current and future strategy, financial and non-financial future results and the environment in which the Group operates, as well as events, operations, future services or product development and potential. Forward-looking statements are generally identified by the words 'expects', 'anticipates', 'believes', 'intends', 'estimates', 'plans' and similar expressions. Forward looking statements and information do not constitute guarantees of future performances, and are subject to known or unknown risks, uncertainties and other factors, a large number of which are difficult to predict and generally outside the control of the Group, which could cause actual results, performances or achievements, or the results of the sector or other events, to differ materially from those described or suggested by these forward-looking statements. These risks and uncertainties include those that are indicated and detailed in Chapter 3 'Risk factors' of the Universal Registration Document filed with the French Financial Markets Authority (Autorité des marchés financiers, AMF) on April 1, 2025. These forward-looking statements are given only as of the date of this press release and the Group expressly declines any obligation or commitment to publish updates or corrections of the forward-looking statements included in this press release in order to reflect any change affecting the forecasts or events, conditions or circumstances on which these forward-looking statements are based. Attachment EUROAPI - Press release - June 4, 2025Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
4 days ago
- Business
- Yahoo
Frédéric Robert appointed EUROAPI's Chief Commercial Officer overseeing API Solutions and CDMO activities
Press Release Paris – June 4, 2025 – EUROAPI, a European leader in the production of active pharmaceutical ingredients (API) and contract development and manufacturing organization (CDMO), is pleased to announce the appointment of Frédéric Robert to the newly created position of Chief Commercial Officer overseeing API Solutions and CDMO activities. He will join the company's Executive Committee. This appointment is part of EUROAPI's ongoing FOCUS-27 transformation plan and reinforces its position as a European leader in the API and CDMO sectors. In his new role, Frédéric Robert will be responsible for creating commercial and organizational synergies between the API Solutions and CDMO operations, delivering our FOCUS-27 sales plan and redefining a global sales strategy for the company. He will also be responsible for expanding the group's presence in its strategic markets and with its strategic clients, and optimizing its customer approach with integrated, high-value-added solutions. 'We are delighted to welcome Frédéric Robert to our team,' said David Seignolle, EUROAPI Chief Executive Officer. 'His extensive expertise in the pharmaceutical industry and CDMO space and his strategic vision for international markets will be invaluable assets to accelerate our growth. This appointment reflects our commitment to enhancing the convergence between our API and CDMO activities to deliver even more integrated and effective solutions for our clients.' Frédéric Robert brings a wealth of experience in the pharmaceutical industry, having held senior leadership roles at NAOS Bioderma, Fareva, and more recently at Aptar, where he served as Vice President of EMEA Sales & Customs Development. He has led several operations across Europe and North America, giving him a comprehensive understanding of the entire value chain, from API production to CDMO and CMO services. Frédéric Robert, Chief Commercial OfficerFrédéric Robert, a French national, joins EUROAPI after more than 25 years of experience in the development and commercialization of pharmaceutical products within international organizations. He previously held the position of Vice President of Sales & Customs Development EMEA at Aptar, overseeing nine commercial regions. Prior to this, Frédéric spent over a decade at Fareva as Senior Vice President of Global Sales & Marketing, where he led global commercial operations and served on the group's Executive Committee. Frédéric has also held several senior roles at Institut Esthederm and NAOS Bioderma, overseeing various subsidiaries across Central Europe and North America. There, he was responsible for business development, subsidiary management, and international expansion. He holds a Master's degree in International Marketing from the Dublin City University and a Master's degree in Business Administration (AES) from the University Jean Moulin Lyon 3. About EUROAPIEUROAPI is focused on reinventing active ingredient solutions to sustainably meet customers' and patients' needs around the world. We are a leading player in active pharmaceutical ingredients with approximately 200 products in our portfolio, offering a large span of technologies while developing innovative molecules through our Contract Development and Manufacturing Organization (CDMO) activities. Taking action for health by enabling access to essential therapies inspires our 3,430 people every day. With strong research and development capabilities and six manufacturing sites, all located in Europe, EUROAPI ensures API manufacturing of the highest quality to supply customers in more than 80 countries. EUROAPI is listed on Euronext Paris; ISIN: FR0014008VX5; ticker: EAPI). Find out more at and follow us on LinkedIn. Media Relations contact:Laurence BollackTel.: +33 (0)6 81 86 80 19mr@ Investor Relations contact:Sophie Palliez-CapianTel.: +33 (0)6 87 89 33 Certain information contained in this press release is forward looking and not historical data. These forward-looking statements are based on opinions, projections and current assumptions including, but not limited to, assumptions concerning the Group's current and future strategy, financial and non-financial future results and the environment in which the Group operates, as well as events, operations, future services or product development and potential. Forward-looking statements are generally identified by the words 'expects', 'anticipates', 'believes', 'intends', 'estimates', 'plans' and similar expressions. Forward looking statements and information do not constitute guarantees of future performances, and are subject to known or unknown risks, uncertainties and other factors, a large number of which are difficult to predict and generally outside the control of the Group, which could cause actual results, performances or achievements, or the results of the sector or other events, to differ materially from those described or suggested by these forward-looking statements. These risks and uncertainties include those that are indicated and detailed in Chapter 3 'Risk factors' of the Universal Registration Document filed with the French Financial Markets Authority (Autorité des marchés financiers, AMF) on April 1, 2025. These forward-looking statements are given only as of the date of this press release and the Group expressly declines any obligation or commitment to publish updates or corrections of the forward-looking statements included in this press release in order to reflect any change affecting the forecasts or events, conditions or circumstances on which these forward-looking statements are based. Attachment EUROAPI - Press release - June 4, 2025Sign in to access your portfolio
Yahoo
26-05-2025
- Business
- Yahoo
Premier Health Announces CFO Transition
MONTRÉAL, May 26, 2025 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the 'Corporation'), a leading Canadian Healthtech company, announces today that it is proceeding with a transition of the CFO functions and appoints Frédéric St-Cyr as Interim Chief Financial Officer, effective immediately. Frédéric St-Cyr is a seasoned professional that has demonstrated strong abilities and leadership in finance and accounting functions including complex IFRS reporting, financing, and risk management in different environments. He started his career as an external auditor and later acted as the Corporate Controller for the Corporation. Frédéric is a member of the Ordre des comptables professionnels agrées du Québec (CPA). Guy Daoust, Premier Health's Chief Financial Officer, agreed to take on the CEO position on an interim basis on March 27th, 2025, which led to the search and hiring of an interim CFO for the transition period. About Premier Health Premier Health is a leading Canadian Healthtech company that provides a comprehensive range of outsourced services solutions for healthcare needs to governments, corporations, and individuals. Premier Health uses its proprietary LiPHe platform to lead the healthcare services sector digital transformation to provide patients with faster, cheaper and more accessible care services. For Further Information Please Contact: Mr. Jean-Robert PronovostVice-President, Corporate DevelopmentPremier Health of America jrpronovost@ 1 800 231 9916 Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This press release contains forward-looking information based on current expectations. Statements about the date of trading of the Corporation's common shares on the Exchange and final regulatory approvals, among others, are forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. The Corporation assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. These factors and others are more fully discussed in the filings of the Corporation with Canadian securities regulatory authorities available at in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Fashion Network
15-05-2025
- Business
- Fashion Network
Vuitton reopens summer restaurant in Saint-Tropez
Vuitton has reopened its summer restaurant in Saint-Tropez, underlining the luxury label's increasing investment in culinary experiences. Located at the plush White 1921 Hotel near the House's historical store, the restaurant reopens today with an updated menu served on the latest colorful Louis Vuitton tableware collection. Last year, Vuitton's Saint-Tropez restaurant was awarded a Michelin star, thanks to its updated Mediterranean fare—from marbled tomatoes and ravioli filled with girolles to roasted fowl with a fine velouté or brill meunière prepared with seaweed and citrus. The reopening also marks this summer's return of hyper-mediatic chefs Arnaud Donckele and Maxime Frédéric to Vuitton in Saint-Tropez. Donckele and Frédéric first connected with Vuitton's parent company, LVMH, at the conglomerate's five-star hotel in the French capital, Cheval Blanc Paris—most notably at Plénitude, the hotel's three-star restaurant. In Saint-Tropez, Vuitton's restaurant is situated on the famed Place des Lices, site of the resort port's renowned Provençal market each Tuesday and Saturday. Beyond Saint-Tropez, Donckele and Frédéric play leading roles in developing the Louis Vuitton Culinary Community, mentoring emerging local talents around the world who, as Members, contribute to the Louis Vuitton luxury snacking vision. Vuitton now boasts eateries in Milan, Tokyo, Osaka and Bangkok, each overseen by chefs within the Culinary Community. Vuitton cafés have also sprung up in Paris, New York, Bangkok, Japan, Chengdu and soon in Shanghai and Seoul. In effect, the Saint-Tropez restaurant is designed to trumpet Vuitton's longer-term vision of extending the House's concept of excellence and savoir-faire to hospitality around the world. 'We are dedicated to bringing customers a relaxed Louis Vuitton culinary experience—whether in Saint-Tropez or any other destination around the world,' said Donckele. Added Frédéric, 'The Culinary Community allows us to align the Louis Vuitton hospitality offering while still encouraging the chefs to flourish according to their own skills and creativity.' The Saint-Tropez space blends a bright floral pattern similar to a motif seen in LV's 2025 Women's Resort collection, designed in a geometric pattern that reinterprets the Monogram Flowers and made in extra-white Limoges porcelain. The ambience is enhanced with reinterpreted Objets Nomades pieces such as the Mini Bell Lamps designed by Barber & Osgerby and Zanellato/Bortotto's lamps enclosed within interwoven leather. Mixing seasonal and regionally sourced ingredients, the menu merges Mediterranean, French and global cuisines—from Wagyu beef in an aromatic bouillon to grilled bluetail lobster with a shiso-infused sauce to sole amidst locally grown herbs and flowers. May the dining begin.
Fashion Network
15-05-2025
- Business
- Fashion Network
Vuitton reopens summer restaurant in Saint-Tropez
Vuitton has reopened its summer restaurant in Saint-Tropez, underlining the luxury label's increasing investment in culinary experiences. Located at the plush White 1921 Hotel near the House's historical store, the restaurant reopens today with an updated menu served on the latest colorful Louis Vuitton tableware collection. Last year, Vuitton's Saint-Tropez restaurant was awarded a Michelin star, thanks to its updated Mediterranean fare—from marbled tomatoes and ravioli filled with girolles to roasted fowl with a fine velouté or brill meunière prepared with seaweed and citrus. The reopening also marks this summer's return of hyper-mediatic chefs Arnaud Donckele and Maxime Frédéric to Vuitton in Saint-Tropez. Donckele and Frédéric first connected with Vuitton's parent company, LVMH, at the conglomerate's five-star hotel in the French capital, Cheval Blanc Paris—most notably at Plénitude, the hotel's three-star restaurant. In Saint-Tropez, Vuitton's restaurant is situated on the famed Place des Lices, site of the resort port's renowned Provençal market each Tuesday and Saturday. Beyond Saint-Tropez, Donckele and Frédéric play leading roles in developing the Louis Vuitton Culinary Community, mentoring emerging local talents around the world who, as Members, contribute to the Louis Vuitton luxury snacking vision. Vuitton now boasts eateries in Milan, Tokyo, Osaka and Bangkok, each overseen by chefs within the Culinary Community. Vuitton cafés have also sprung up in Paris, New York, Bangkok, Japan, Chengdu and soon in Shanghai and Seoul. In effect, the Saint-Tropez restaurant is designed to trumpet Vuitton's longer-term vision of extending the House's concept of excellence and savoir-faire to hospitality around the world. 'We are dedicated to bringing customers a relaxed Louis Vuitton culinary experience—whether in Saint-Tropez or any other destination around the world,' said Donckele. Added Frédéric, 'The Culinary Community allows us to align the Louis Vuitton hospitality offering while still encouraging the chefs to flourish according to their own skills and creativity.' The Saint-Tropez space blends a bright floral pattern similar to a motif seen in LV's 2025 Women's Resort collection, designed in a geometric pattern that reinterprets the Monogram Flowers and made in extra-white Limoges porcelain. The ambiance is enhanced with reinterpreted Objets Nomades pieces such as the Mini Bell Lamps designed by Barber & Osgerby and Zanellato/Bortotto's lamps enclosed within interwoven leather. Mixing seasonal and regionally sourced ingredients, the menu merges Mediterranean, French and global cuisines—from Wagyu beef in an aromatic bouillon to grilled bluetail lobster with a shiso-infused sauce to sole amidst locally grown herbs and flowers. May the dining begin.
